JAZZJazz Pharmaceuticals plcvs its industry peers
A metric-by-metric comparison of Jazz Pharmaceuticals plc against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JAZZEsta | $17.0B#6 | 17.9x#2 | 3.5x#2 | 4.0x#3 | 4.9%#10 | -163.6%#12 | -10.1%#7 | -7.4%#8 | -5.7%#4 | — | 125.1%#2 | — |
| ZTS | $31.9B#1 | 12.5x#1 | 9.9x#6 | 3.4x#1 | 2.3%#11 | 7.5%#6 | 37.8%#2 | 82.7%#1 | 26.3%#2 | — | -48.6%#8 | 2.8%#1 |
| ALNY | $29.3B#2 | 38.2x#4 | 21.6x#8 | 7.9x#5 | 65.2%#6 | 212.8%#1 | 13.5%#3 | 23.2%#2 | 150.5%#1 | — | -47.8%#7 | — |
| ROIV | $24.9B#3 | — | 5.5x#4 | 3014.7x#12 | -71.6%#12 | -74.3%#11 | -6235.7%#12 | -6.6%#7 | -15.4%#5 | — | 200.7%#1 | — |
| UTHR | $22.0B#4 | 19.2x#3 | 3.7x#3 | 6.9x#4 | 10.6%#9 | 11.7%#5 | 46.9%#1 | 22.6%#3 | — | — | 77.0%#3 | — |
| INSM | $21.4B#5 | — | 30.4x#11 | 35.3x#11 | 66.7%#4 | -39.7%#10 | -205.6%#11 | -181.1%#11 | -185.1%#7 | 4#1 | -11.3%#6 | — |
| BBIO | $16.1B#7 | — | — | 32.0x#10 | 126.3%#3 | — | -104.2%#10 | — | — | — | — | 0.0%#2 |
| ARWR | $12.7B#8 | — | 27.2x#10 | 15.3x#7 | 23258.2%#1 | 99.7%#2 | 11.9%#5 | -0.4%#6 | — | — | — | — |
| CORT | $11.9B#9 | 243.9x#6 | 16.8x#7 | 15.6x#8 | 12.8%#8 | -29.4%#9 | 5.9%#6 | 14.1%#4 | — | — | — | — |
| MDGL | $11.7B#11 | — | 22.4x#9 | 12.2x#6 | 432.1%#2 | 38.1%#3 | -31.3%#9 | -55.0%#10 | -52.5%#6 | — | 62.1%#4 | — |
| BMRN | $11.7B#10 | 43.7x#5 | 1.9x#1 | 3.6x#2 | 12.9%#7 | -18.3%#8 | 12.7%#4 | 5.6%#5 | 5.5%#3 | — | 0.6%#5 | — |
| AXSM | $10.9B#12 | — | 200.1x#12 | 17.1x#9 | 65.5%#5 | 36.2%#4 | -26.1%#8 | -335.6%#12 | — | — | — | — |
| GPCR | $10.6B#13 | — | 7.3x#5 | — | — | -15.2%#7 | — | -9.8%#9 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-08-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice